ReviewWorld journal of gastroenterology2017

Indoleamine 2,3-dioxygenase: As a potential prognostic marker and immunotherapeutic target for hepatocellular carcinoma.

Kashif Asghar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.